tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market

Compare Monte Rosa Therapeutics (GLUE) vs. Competitors

Compare
370 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Monte Rosa Therapeutics
$20.93
$1.49B
63.95
192.80%
8 Buy
0 Hold
0 Sell
Strong Buy
CytomX Therapeutics
$6.07
$960.70M
13.56
557.01%
6 Buy
1 Hold
0 Sell
Strong Buy
Fulcrum Therapeutics
$9.90
$653.11M
-8.40
159.16%
9 Buy
1 Hold
1 Sell
Moderate Buy
Monopar Therapeutics Inc
$66.89
$397.15M
-17.28
23.81%
11 Buy
0 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$85.32
$1.20B
-8.07
539.50%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GLUE
Monte Rosa Therapeutics
19.53
12.69
185.53%
CTMX
CytomX Therapeutics
5.67
4.73
503.19%
FULC
Fulcrum Therapeutics
9.90
5.99
153.20%
MNPR
Monopar Therapeutics Inc
59.43
10.66
21.86%
OPT
INBX
Inhibrx Biosciences Inc
82.56
69.00
508.85%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts